Skip to content

Recent
Transactions

We represent foreign and domestic clients in a broad range of capital raising, M&A and other corporate transactions. Below are tombstone listings of certain of our recent representative transactions. Please click on a tombstone for a description of the specific deal.

All
  • All
  • Cryptocurrency
  • IPOs and Public Offerings
  • M&A
  • Other
  • PIPES and Private Placements
  • Private Fund
  • SPAC

QMMM Holdings Limited $8,600,000

Initial Public Offering

August 2024

Press Release ›

MKDWELL Tech Inc.

Business Combination

August 2024

Press Release ›

OS Therapies Incorporated $6,400,000

Initial Public Offering

August 2024

Press Release ›

Nature’s Miracle Holding Inc. $1,200,000

Common Stock and Warrants

August 2024

Press Release ›

Serve Robotics Inc. $10,800,000

Registered Direct Offering

July 2024

Press Release ›

VCI Global Ltd $3,000,000

Registered Direct Offering

July 2024

Press Release ›

Shineco, Inc. $2,000,000

Public Offering

July 2024

Press Release ›

Datasea Inc. $2,250,000

Registered Direct Offering

July 2024

Press Release ›

Ayurcann Holdings Corp.

Business Combination

June 2024

Press Release ›

authID, Inc. $11,000,000

Registered Direct Offering

June 2024

Press Release ›

Kaival Brands $6,000,000

Public Offering

June 2024

Press Release ›

Presidio Property Trust, Inc. $1,750,000

Series D Preferred Stock

June 2024

Press Release ›

Sharps Technology, Inc. $3,400,000

Reg A+ Warrant Inducement

June 2024

Press Release ›

BioSig Technologies, Inc. $3,000,000

Registered Direct Offering

May 2024

Press Release ›

BriaCell Therapeutics Corp. $5,000,000

Registered Direct Offering

May 2024

Press Release ›

Siyata Mobile $4,000,000

Public Offering

May 2024

Press Release ›

INmune Bio Inc. $9,700,000

Registered Direct Offering

April 2024

Press Release ›

INmune Bio Inc. $4,800,000

Registered Direct Offering

April 2024

Press Release ›

Genetic Technologies Limited $2,000,000

Registered Direct Offering

April 2024

Press Release ›

NRx Pharmaceuticals, Inc. $2,000,000

Common Stock Offering

April 2024

Press Release ›